Abstract
Retroviral vector particles (RVP) which are resistant to inactivation by human serum will be needed for many in vivo gene therapy applications. Murine-based producer cell lines generate RVP which are inactivated by human serum, reportedly due to the presence of the galactosyl (α1–3) galactosyl carbohydrate moiety (αGal) on these and other nonprimate producer cells and RVP. Consequently, human cells (which lack the αGal moiety) have been developed as producer cell lines for generation of human serum-resistant RVP. In this study, we report that contrary to earlier reports, the presence of the αGal moiety on producer cells and RVP does not necessarily correlate with cell killing or RVP inactivation by human serum. We show that the αGal-positive ferret brain cell line, Mpf, is an excellent basal cell line for generation of RVP which have titers and serum resistance levels equal to or greater than RVP produced in human cell lines such as HT1080. Therefore, packaging cell lines need not be limited to those of human or primate origin for production of human serum-resistant RVP.
Similar content being viewed by others
References
Welsh RM, Cooper NR, Jensen FC, Oldstone MBA . Human serum lyses RNA tumor viruses Nature 1975 257: 612–614
Welsh RM . Host cell modification of lymphocytic choriomeningitis virus and Newcastle disease virus altering viral inactivation by human complement J Immunol 1977 118: 348–354
Bartholomew RM, Esser AF, Muller-Eberhard HJ . Lysis of oncornaviruses by human serum J Exp Med 1978 147: 844–853
Repik PM, Strizki JM, Galili U . Differential host-dependent expression of α-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model J Gen Virol 1994 75: 1177–1181
Rother RP et al. A novel mechanism of retrovirus inactivation in human serum mediated by anti-α-galactosyl natural antibody J Exp Med 1995 182: 1345–1355
Takeuchi Y et al. Sensitization of cells and retroviruses to human serum by α(1–3) galactosyltransferase Nature 1996 379: 85–88
Takeuchi YM et al. Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl (α1–3) galactosylation J Virol 1997 71: 6174–6178
Takeuchi Y et al. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell J Virol 1994 68: 8001–8007
Pensiero MN, Wysocki CA, Nader K, Kikuchi GE . Development of amphotropic murine retrovirus vectors resistant to inactivation by human serum Hum Gene Ther 1996 7: 1095–1101
Cosset FL et al. High-titer packaging cells producing recombinant retroviruses resistant to human serum J Virol 1995 69: 7430–7436
Cornetta K et al. Infection of human cells with murine amphotropic replication-competent retroviruses Hum Gene Ther 1993 4: 579–588
O’Neill RR et al. Envelope and long terminal sequences of cloned infectious NZB xenotropic murine leukemia virus J Virol 1985 53: 100–106
Khan AS . Nucleotide sequence analysis establishes the role of endogenous murine leukemia virus DNA segments in formation of recombinant mink cell focus-forming murine leukemia viruses J Virol 1984 50: 864–871
Hoshino H, Tanaka H, Miwa M, Okada H . Human T-cell leukaemia virus is not lysed by human serum Nature 1984 310: 324–325
Miller AD, Rosman GJ . Improved retroviral vectors for gene transfer and expression BioTechniques 1989 7: 980–990
Loiler SA, DiFronzo NL, Holland CA . Gene transfer to human cells using retrovirus vectors produced by a new polytropic packaging cell line J Virol 1997 71: 4825–4828
Markowitz D, Goff S, Bank A . A safe packaging line for gene transfer: separating viral genes on two different plasmids J Virol 1988 62: 1120–1124
Soumalainen M, Garoff H . Incorporation of homologous and heterologous proteins into the envelope of moloney murine leukemia virus J Virol 1994 68: 4879–4889
Goochee CF et al. The oligosaccharides of glycoproteins: bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties Biotechnology 1991 9: 1347–1355
Galili U, Macher BA, Buehler J, Shohet SB . Human natural anti-α-galactosyl IgG J Exp Med 1985 162: 573–582
Davis JK, Cassell GH, Minion FC, Wise KS . Mycoplasma host-cell interactions resulting in chronic inflammation: acquisition of host antigens and other mechanisms Isr J Med Sci 1981 17: 633–636
Schofield L . The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite? WHO Bulletin OMS Suppl 1990 68: 66–73
Goldring OL, Clegg JA, Smithers SR, Terry RJ . Acquisition of human blood group antigens by Schistosoma mansoni J Clin Exp Immunol 1976 26: 181–187
Wrightsman RA, Dawson BD, Fouts DL, Manning JE . Identification of immunodominant epitopes in Trypanosoma cruzi trypomastigote surface antigen-1 protein that mask protective epitopes J Immunol 1994 153: 3148–3154
Kaluza G, Rott R, Schwarz RT . Carbohydrate-induced conformational changes of Semiliki forest virus glycoproteins determine antigenicity Virology 1980 102: 286–299
Skehel JJ et al. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody Proc Natl Acad Sci USA 1984 81: 1779–1783
Olofsson S, Sjoblom I, Jeansson S . Activity of herpes simplex virus type 1-specified glycoprotein C antigenic site epitopes reversibly modulated by peripheral fucose or galactose units of glycoprotein oligosaccharides J Gen Virol 1990 71: 889–895
Benjouad A et al. Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160 J Virol 1992 66: 2473–2483
Andersen KB . A domain of murine retrovirus surface protein gp70 mediates cell fusion, as shown in a novel SC-1 cell fusion system J Virol 1994 68: 3175–3182
Kayman S et al. Mutational analysis of N-linked glycosylation sites of Friend murine leukemia virus envelope protein J Virol 1991 65: 5323–5332
Goff SP, Traktman P, Baltimore D . Isolation and properties of moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase J Virol 1981 38: 239–248
Morgan RA et al. Analysis of the functional and host range-determining regions of the murine ecotropic and amphotropic retrovirus envelope proteins J Virol 1993 67: 4712–4721
Stirling JW . Immuno and affinity probes for electron microscopy: a review of labeling and preparation techniques J Hist Cytochem 1990 38: 145–157
Acknowledgements
We thank Michele Barcia for fine technical assistance and members of the North Shore University Hospital core facilities, Craig Gawel, Colleen Millan, and Sara Danzi for DNA sequencing, and Cathy Rapelje for flow cytometry. This work was supported in part by the Boas-Marks-Spiro Gene Therapy Vector Laboratory.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mason, J., Guzowski, D., Goodwin, L. et al. Human serum-resistant retroviral vector particles from galactosyl (α1–3) galactosyl containing nonprimate cell lines. Gene Ther 6, 1397–1405 (1999). https://doi.org/10.1038/sj.gt.3300963
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300963
- Springer Nature Limited